This protocol addresses the management of severe hirsutism — specifically in women experiencing emotional distress related to the condition, or in those who have previously used oral contraceptives without achieving sufficient improvement.
This approach applies when one or more of the following is present:
The recommended strategy moves beyond oral contraceptive monotherapy to combination treatment, pairing an oral contraceptive with an antiandrogen agent. The full protocol details which antiandrogen options are indicated for this population, and identifies one agent that is recommended against on safety grounds.
The primary clinical target is measurable improvement in hirsutism, assessed by a reduction in the Ferriman–Gallwey hirsutism score.
DOI: 10.1210/jc.2018-00241